Esperion Therapeutics
ESPR
ESPR
141 hedge funds and large institutions have $1.38B invested in Esperion Therapeutics in 2015 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 45 increasing their positions, 26 reducing their positions, and 7 closing their positions.
Holders
141
Holders Change
+57
Holders Change %
+67.86%
% of All Funds
3.76%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
64
Increased
45
Reduced
26
Closed
7
Calls
$46.4M
Puts
$43.5M
Net Calls
+$2.95M
Net Calls Change
+$2.42M
Top Buyers
1 |
VAM
1
Visium Asset Management
New York
|
$130M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$202M |
3 |
GGHC
3
Gilder Gagnon Howe & Co
New York
|
$74.6M |
4 |
4
State Street
Boston,
Massachusetts
|
$36.4M |
5 |
CCI
5
Columbus Circle Investors
|
$22.9M |